Investigation of the prognostic value of coexpressed erbB family members for the survival of colorectal cancer patients after curative surgery

European Journal of Cancer

Volumn 38, Issue 8, 2002, Pages 1065-1071

  Lee, J C ^a   Wang, S T ^a   Chow, N H ^a   Yang, H B ^b  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b Ton Yen General Hospital   (Taiwan)

Author keywords

Colorectal cancer; Epidermal growth factor receptor; erbB2; erbB3; erbB4; Heterodimer; Subtype I receptor tyrosine kinase

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPIDERMAL GROWTH FACTOR RECEPTOR 4; PARAFFIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CLASSIFICATION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARCINOGENESIS; COLON; COLORECTAL CARCINOMA; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SCORING SYSTEM; SURVIVAL TIME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLORECTAL NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM PROTEINS; PEDIGREE; PREOPERATIVE CARE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECEPTOR, ERBB-2; SURVIVAL ANALYSIS;

EID: 0036251746     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(02)00004-7     Document Type: Article

References (38)

1. Signal transduction by receptors with tyrosine kinase activity
2. Epidermal growth factor receptors status as predictor of early recurrence and death from breast cancer
3. Clinical significance of the expression of epidermal growth factor and its receptor in esophageal cancer
4. Expression of epidermal growth factor receptor in human gastric and colonic carcinomas
5. Prognostic utility of epidermal growth factor receptor overexpression in endometrial adenocarcinoma
6. Prognostic value of epidermal growth factor receptor expression in cervical carcinoma
7. Expression of c-erbB-2 oncoprotein:A prognostic indicator in human breast cancer
8. An evaluation of immunoreactivity for c-erbB-2 protein as a marker of poor short-term prognosis in breast cancer
9. Studies of the HER-2/neu Proto-Oncogene in human breast and ovarian cancer
10. Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short term prognosis in gastric cancer
11. Coexpression of erb B2 and erb B3 proteins reconstitutes a high affinity receptors for heregulin
12. Ligand-specific activation of HER4/P180 erb B4, a fourth member of the epidermal growth factor receptor family
13. Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor family: Evidence for overexpression in a subset of human mammary tumors
14. Expression of the ERBB3 gene product in breast cancer
15. C-erbB-3 in human breast carcinoma: Expression and relation to prognosis and established prognostic indicators
16. ErbB-3 and ErbB-4 function as the respective low and high affinity receptors of all neu differentiation factor heregulin isoforms
17. Intermolecular association of the p185neu protein and EGF receptor modulates EGF receptor function
18. The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor and mdr gene expression in colorectal cancer
19. Study of c-erbB-2 protein and epidermal growth factor receptor expression and DNA ploidy pattern in colorectal carcinoma
20. Increased expression of erb B3 in colorectal cancer is associated with concomitant increase in the level of erb B2
21. Epidermal growth factor receptor expression in colorectal cancer
22. Clinical relevance of transforming growth factor α, epidermal growth factor receptor, P53 and Ki67 in colorectal liver metastasis and corresponding primary tumors
23. Expression of the c-erbB-2 gene product (P185) at different stages of neoplastic progression in the colon
24. Receptors for epidermal growth factor and steroid hormones in primary colorectal tumors
25. Correlation of epidermal growth factor receptor and c-erbB2 oncogene product to known prognostic indicators of colorectal cancer
26. Prognostic significance of direct extension of carcinoma of colon and rectum
27. Detection of c-erbB-2 activation in paraffin- embedded tissue by immunohistochemistry
28. Expression of c-erbB-2 protein in normal and neoplastic urothelium: Lack of adverse prognostic effect in human urinary bladder cancer
29. Expression of the c-erbB-3 protein in gastrointestinal tract tumors determined by monoclonal antibody RTJ 1
30. Expression of the c-erbB-3 protein in normal human adult and fetal tissues
31. Expression patterns of erbB receptor family in normal urothelium and transitional cell carcinoma
32. Overexpression of HER 2/neu oncogene in human pancreatic carcinoma
33. Neu differentiation factor: A transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit
34. Lack of prognostic significance of epidermal growth factor receptor and the oncoprotein P185HER-2 in patients with systemically untreated non-small-cell lung cancer: An immunohistochemical study on cryosections
35. Prognostic significance of the expression of c-fos, c- jun and c-erbB-1 oncogene products in human squamous cell lung carcinomas
36. The prognostic value of epidermal growth factor receptors, determined by both immunohistochemistry and ligand assays, in primary epithelial ovarian cancer: A pilot study